These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18282668)

  • 1. Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity.
    Hozumi H; Asanuma M; Miyazaki I; Fukuoka S; Kikkawa Y; Kimoto N; Kitamura Y; Sendo T; Kita T; Gomita Y
    Toxicol Lett; 2008 Mar; 177(2):123-9. PubMed ID: 18282668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y; Gandia C; Huang PL; Ali SF
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
    Albers DS; Sonsalla PK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.
    Wu PH; Shen YC; Wang YH; Chi CW; Yen JC
    Toxicology; 2006 Sep; 226(2-3):238-45. PubMed ID: 16887252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
    Hagiwara H; Iyo M; Hashimoto K
    Brain Res; 2009 Dec; 1301():189-96. PubMed ID: 19748494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse.
    Anderson KL; Itzhak Y
    Ann N Y Acad Sci; 2006 Aug; 1074():225-33. PubMed ID: 17105919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen.
    Tsuji T; Asanuma M; Miyazaki I; Miyoshi K; Ogawa N
    Neurochem Res; 2009 Apr; 34(4):764-74. PubMed ID: 18946735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
    Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.
    Kawasaki T; Ishihara K; Ago Y; Nakamura S; Itoh S; Baba A; Matsuda T
    Eur J Pharmacol; 2006 Aug; 542(1-3):92-9. PubMed ID: 16784740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of methamphetamine neurotoxicity in forensic autopsy cases.
    Kitamura O
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S63-5. PubMed ID: 19269222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effects of alpha-phenyl-N-tert-butyl nitrone pretreatment on the neurobehavioral effects of methamphetamine.
    Kita T; Matsunari Y; Saraya T; Shimada K; O'Hara K; Kubo K; Wagner GC; Nakashima T
    Life Sci; 2000 Aug; 67(13):1559-71. PubMed ID: 10983851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.
    Zhang L; Kitaichi K; Fujimoto Y; Nakayama H; Shimizu E; Iyo M; Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1381-93. PubMed ID: 16839653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New perspectives on the mechanism of methamphetamine-induced neurotoxicity].
    Kita T; Takeshima M; Wagner GC; Hozumi H; Miyazaki I; Asanuma M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Apr; 28(2):49-61. PubMed ID: 18516983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
    Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules.
    Miyazaki I; Asanuma M; Diaz-Corrales FJ; Fukuda M; Kitaichi K; Miyoshi K; Ogawa N
    FASEB J; 2006 Mar; 20(3):571-3. PubMed ID: 16403784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific gene expression and possible involvement of inflammation in methamphetamine-induced neurotoxicity.
    Asanuma M; Miyazaki I; Higashi Y; Tsuji T; Ogawa N
    Ann N Y Acad Sci; 2004 Oct; 1025():69-75. PubMed ID: 15542702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
    Bourque M; Liu B; Dluzen DE; Di Paolo T
    Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice.
    Iwashita A; Mihara K; Yamazaki S; Matsuura S; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1114-24. PubMed ID: 15113847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.